NASDAQ:CMECME Group Stock Price, Forecast & News

$184.51

-1.75 (-0.94 %)

(As of 06/4/2020 04:00 PM ET)

Add

Compare

Today's Range

$181.77

Now: $184.51▼

$186.18

50-Day Range

$173.65

MA: $181.33▼

$191.62

52-Week Range

$131.80

Now: $184.51▼

$225.36

Volume1.63 million shs

Average Volume2.16 million shs

Market Capitalization$66.16 billion

P/E Ratio27.70

Dividend Yield1.83%

Beta0.32

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions; and provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services. It also offers transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, analytics, and regulatory reporting. In addition, the company provides a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Beat the Market (BTM) Rank^™

2.1 Analyst's Opinion

Consensus Rating
CME Group has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 6 buy ratings, 6 hold ratings, and 3 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $194.14, CME Group has a potential upside of 5.2% from its current price of $184.51.
Amount of Analyst Coverage
CME Group has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.4 Community Rank

Outperform Votes
CME Group has received 612 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CME Group has received 656 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CME Group has received 51.74% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CME Group and other stocks. Vote “Outperform” if you believe CME will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CME will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
CME Group is a leading dividend payer. It pays a dividend yield of 1.83%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
CME Group has been increasing its dividend for 9 years.
Dividend Coverage
The dividend payout ratio of CME Group is 50.00 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, CME Group will have a dividend payout ratio of 45.33 % next year. This indicates that CME Group will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CME Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $541,980.00 in company stock.
Percentage Held by Insiders
Only 1.20% of the stock of CME Group is held by insiders.
Percentage Held by Institutions
84.93% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Earnings Growth
Earnings for CME Group are expected to decrease by -2.72% in the coming year, from $7.71 to $7.50 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CME Group is 27.70, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.21.
Price to Earnings Ratio vs. Sector
The P/E ratio of CME Group is 27.70, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 20.00.
Price to Earnings Growth Ratio
CME Group has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
CME Group has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.93 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Security & commodity brokers, dealers, exchanges & services

Sub-IndustrySpecialized Finance

SectorFinance

Current SymbolNASDAQ:CME

Previous Symbol

CUSIP12572Q10

CIK1156375

Webwww.cmegroup.com

Phone312-930-1000

Debt

Debt-to-Equity Ratio0.13

Current Ratio1.01

Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio27.70

Forward P/E Ratio23.93

P/E Growth4.41

Sales & Book Value

Annual Sales$4.87 billion

Price / Sales13.59

Cash Flow$8.39 per share

Price / Cash Flow21.98

Book Value$73.18 per share

Price / Book2.52

Profitability

EPS (Most Recent Fiscal Year)$6.80

Net Income$2.12 billion

Net Margins45.79%

Return on Equity10.15%

Return on Assets2.97%

Miscellaneous

Employees4,360

Outstanding Shares358,588,000

Market Cap$66.16 billion

Next Earnings Date7/29/2020 (Estimated)

OptionableOptionable

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

CME Group (NASDAQ:CME) Frequently Asked Questions

How has CME Group's stock been impacted by COVID-19 (Coronavirus)?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CME stock has decreased by 5.2% and is now trading at $184.51. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CME Group?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 3 sell ratings, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for CME Group.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CME Group.

How were CME Group's earnings last quarter?

CME Group Inc (NASDAQ:CME) posted its quarterly earnings data on Wednesday, April, 29th. The financial services provider reported $2.33 earnings per share for the quarter, beating analysts' consensus estimates of $2.23 by $0.10. The financial services provider earned $1.52 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 45.79% and a return on equity of 10.15%. The firm's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.62 EPS. View CME Group's earnings history.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group announced a quarterly dividend on Wednesday, May 6th. Stockholders of record on Wednesday, June 10th will be given a dividend of $0.85 per share on Thursday, June 25th. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend is Tuesday, June 9th. View CME Group's dividend history.

What price target have analysts set for CME?

15 brokerages have issued 12 month target prices for CME Group's stock. Their forecasts range from $152.00 to $227.00. On average, they anticipate CME Group's stock price to reach $194.14 in the next year. This suggests a possible upside of 5.2% from the stock's current price. View analysts' price targets for CME Group.

Has CME Group been receiving favorable news coverage?

News stories about CME stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. CME Group earned a coverage optimism score of -2.6 on InfoTrie's scale. They also gave news stories about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutCME Group.

Are investors shorting CME Group?

CME Group saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,600,000 shares, an increase of 7.3% from the April 30th total of 5,220,000 shares. Based on an average daily trading volume, of 2,580,000 shares, the short-interest ratio is currently 2.2 days. Approximately 1.6% of the shares of the company are short sold. View CME Group's Current Options Chain.

Who are some of CME Group's key competitors?

Some companies that are related to CME Group include Intercontinental Exchange (ICE), Moody's (MCO), Msci (MSCI), Nasdaq (NDAQ), MarketAxess (MKTX), Interactive Brokers Group (IBKR), Cboe Global Markets (CBOE), Arrow Financial (AROW), Gain Capital (GCAP), California First National Bancorp (CFNB) and Marlin Business Services (MRLN). View all competitors.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Walt Disney (DIS), Boeing (BA), Mastercard (MA), Visa (V), Alibaba Group (BABA), Paypal (PYPL), Cisco Systems (CSCO), Intel (INTC) and Netflix (NFLX).

Who are CME Group's key executives?

CME Group's management team includes the following people:

Mr. Terrence A. Duffy, Chairman & CEO (Age 61)
Mr. Bryan Thomas Durkin, Pres (Age 58)
Mr. John W. Pietrowicz M.B.A., CPA, Sr. MD & CFO (Age 54)
Ms. Julie Holzrichter, Sr. MD & COO (Age 50)
Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 55)

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by many different retail and institutional investors. Top institutional investors include Capital World Investors (9.75%), BlackRock Inc. (7.43%), State Street Corp (4.47%), Capital Research Global Investors (3.50%), Capital International Investors (3.23%) and Edgewood Management LLC (2.19%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View institutional ownership trends for CME Group.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Magellan Asset Management Ltd, Capital Research Global Investors, Primecap Management Co. CA, Capital World Investors, Morgan Stanley, Capital International Investors, Janus Henderson Group PLC, and Vontobel Asset Management Inc.. Company insiders that have sold CME Group company stock in the last year include Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, and Timothy S Bitsberger. View insider buying and selling activity for CME Group.

Which major investors are buying CME Group stock?

CME stock was purchased by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Viking Global Investors LP, BlackRock Inc., California Public Employees Retirement System, Caisse DE Depot ET Placement DU Quebec, Parnassus Investments CA, Edgewood Management LLC, and Fred Alger Management LLC. View insider buying and selling activity for CME Group.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $184.51.

How big of a company is CME Group?

CME Group has a market capitalization of $66.16 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis. CME Group employs 4,360 workers across the globe.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff